EQS-News: Catalyst Crew Technologies to Attend HLTH Europe 2026
Source: EQS|
Dr. Levy’s attendance is intended to support the Company’s broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of the Company’s evolving digital health ecosystem. The Company believes that attendance at major international healthcare conferences may provide valuable opportunities to observe industry developments, strengthen professional networks, and support its broader efforts to advance its telehealth and artificial intelligence healthcare platform strategy The Company continues to advance the development of its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, leadership initiatives, strategic transactions, operational execution, regulatory matters, and future operations. Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to the Company’s ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market and economic conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. The Company is a development-stage enterprise and has not generated revenues from its newly announced business direction. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues. Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact News Source:
|
| Language: | English |
| Company: | |
| ISIN: | US21116R3057 |
| EQS News ID: | 2315934 |
| End of News | |
|
|
2315934 27.04.2026 CET/CEST